Julie Waras Brogren

Deputy CEO & Chief Commercial Officer at Ascelia Pharma

Julie Waras Brogren (born 1972) has extensive experience in life science leadership roles in finance, global product launches, and general management. She was previously President of BresoTEC, a Canada HealthTech and has held various leadership positions at Novo Nordisk in Latin America and in global teams, including as head of the Global Launch Office for the Victoza GLP-1 and degludec insulin. Julie Waras Brogren also has experience as a Board member of life science companies. Julie Waras Brogren started her career at Accenture.

Links

Previous companies

Novo Nordisk logo

Timeline

  • A

    Deputy CEO & Chief Commercial Officer

    October, 2022 - present